HUTCHMED (China) LimitedHCMNASDAQ
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank36
Year-over-Year Change
Year-over-year research & development expense growth
Latest
0.00%
↓ 100% vs avg
Percentile
P36
Within normal range
Streak
1 qtr
Consecutive growthDecelerating
Average
0.34%
Historical baseline
| Period | Value |
|---|---|
| Q2 2025 | 0.00% |
| Q1 2025 | -39.05% |
| Q4 2024 | 0.00% |
| Q3 2024 | 23.99% |
| Q2 2024 | 0.00% |
| Q1 2024 | -39.87% |
| Q4 2023 | 0.00% |
| Q3 2023 | 9.53% |
| Q2 2023 | 0.00% |
| Q1 2023 | -31.03% |
| Q4 2022 | 0.00% |
| Q3 2022 | -42.31% |
| Q2 2022 | 100.00% |
| Q1 2022 | 187.33% |
| Q4 2021 | -218.22% |
| Q3 2021 | 33.38% |
| Q2 2021 | 15.65% |
| Q1 2021 | 151.17% |
| Q4 2020 | -317.76% |
| Q3 2020 | 17.81% |
| Q2 2020 | 42.45% |
| Q1 2020 | 132.81% |
| Q4 2019 | -395.71% |
| Q3 2019 | -33.51% |
| Q2 2019 | 115.13% |
| Q1 2019 | -60.81% |
| Q4 2018 | 95.63% |
| Q3 2018 | -26.91% |
| Q2 2018 | 88.52% |
| Q1 2018 | -51.83% |
| Q4 2017 | 92.74% |
| Q3 2017 | -28.99% |
| Q2 2017 | 100.00% |
| Q1 2017 | -14.58% |
| Q4 2016 | 0.00% |
| Q3 2016 | 18.51% |
| Q2 2016 | 0.00% |
| Q1 2016 | 2.06% |
| Q4 2015 | -35.53% |
| Q3 2015 | 122.93% |